Yumin Xu
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Liver Disease and Transplantation
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Epidemiology 21
- Liver Disease Diagnosis and Treatment 17
- Hepatitis B Virus Studies 12
- Hepatology 14
- Hepatitis C virus research 8
- Liver Disease and Transplantation 5
- Co-authors
- Xiaogang Xiang (10 shared papers)Qing Xie (13 shared papers)Zhujun Cao (10 shared papers)Hui Wang (12 shared papers)Shisan Bao (13 shared papers)Gangde Zhao (11 shared papers)Yuhan Liu (6 shared papers)Wei Cai (7 shared papers)
- Journals
- Infection and Drug Resistance (4 papers)Liver International (2 papers)Acta Biochimica et Biophysica Sinica (2 papers)Frontiers in Physiology (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Yumin Xu
39 papers receiving 508 citations
Peers
Comparison fields: 5 of 69
- Hepatology 203
- Cancer Research 119
- Epidemiology 266
- Pharmacology 34
- Molecular Biology 183
Countries citing papers authored by Yumin Xu
This map shows the geographic impact of Yumin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumin Xu more than expected).
Fields of papers citing papers by Yumin Xu
This network shows the impact of papers produced by Yumin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumin Xu. The network helps show where Yumin Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yumin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 52 | |
| 2 | 2017 | 41 | |
| 3 | 2014 | 40 | |
| 4 | 2020 | 33 | |
| 5 | 2019 | 32 | |
| 6 | 2018 | 27 | |
| 7 | 2020 | 25 | |
| 8 | 2013 | 23 | |
| 9 | 2014 | 22 | |
| 10 | 2013 | 17 | |
| 11 | 2017 | 17 | |
| 12 | 2019 | 16 | |
| 13 | The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma. | 2014 | 16 |
| 14 | 2021 | 14 | |
| 15 | 2023 | 13 | |
| 16 | 2018 | 12 | |
| 17 | 2009 | 11 | |
| 18 | 2014 | 11 | |
| 19 | 2020 | 10 | |
| 20 | 2012 | 9 |
About Yumin Xu
Yumin Xu is a scholar working on Epidemiology, Hepatology, Molecular Biology, Oncology and Cancer Research, having authored 41 papers that have together received 516 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (8 papers), Liver Disease and Transplantation (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Hepatology (203 citations), Cancer Research (119 citations), Epidemiology (266 citations), Pharmacology (34 citations) and Molecular Biology (183 citations). Yumin Xu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Xiaogang Xiang, Qing Xie, Zhujun Cao, Hui Wang, Shisan Bao, Gangde Zhao, Yuhan Liu, Wei Cai, Ziqiang Li and Kehui Liu. Their work appears in journals such as Infection and Drug Resistance, Liver International, Acta Biochimica et Biophysica Sinica, Frontiers in Physiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.